Rachel A. Pozzar, Niya Xiong, Fangxin Hong, Christopher P. Filson, Peter Chang, Barbara Halpenny, Donna L. Berry. Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions. BMC Med. Inf. & Decision Making, 22(1):223, 2022. [doi]
@article{PozzarXHFCHB22,
title = {Concordance between influential adverse treatment outcomes and localized prostate cancer treatment decisions},
author = {Rachel A. Pozzar and Niya Xiong and Fangxin Hong and Christopher P. Filson and Peter Chang and Barbara Halpenny and Donna L. Berry},
year = {2022},
doi = {10.1186/s12911-022-01972-w},
url = {https://doi.org/10.1186/s12911-022-01972-w},
researchr = {https://researchr.org/publication/PozzarXHFCHB22},
cites = {0},
citedby = {0},
journal = {BMC Med. Inf. & Decision Making},
volume = {22},
number = {1},
pages = {223},
}